Alnylam Pharmaceuticals, Inc. (ALNY) RNAi Roundtable: Exon 1 Targeting With Brezosiran for Huntington's Disease - Slideshow (NASDAQ:ALNY) 2026-10-30

seekingalpha.com · 2026-10-30

2026-10-30. The following slide deck was published by Alnylam Pharmaceuticals, Inc.